Suppr超能文献

病毒特异性 CD8+ T 细胞应答比 HLA 基因型更能定义 HIV 疾病进展。

Virus-specific CD8+ T-cell responses better define HIV disease progression than HLA genotype.

机构信息

Vaccine and Infectious Disease Institute, Statistical Center for HIV Research and Prevention, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.

出版信息

J Virol. 2010 May;84(9):4461-8. doi: 10.1128/JVI.02438-09. Epub 2010 Feb 10.

Abstract

HLA alleles B57/58, B27, and B35 have the strongest genetic associations with HIV-1 disease progression. The mechanisms of these relationships may be host control of HIV-1 infection via CD8(+) T-cell responses. We examined these immune responses in subjects from the Seattle Primary Infection Cohort with these alleles. CD8(+) T-cell responses to conserved HIV epitopes within B57/58 alleles (TW10 and KF11) and B27 alleles (KK10 and FY10) delayed declines in CD4(+) T-cell counts (4 to 8 times longer), while responses to variable epitopes presented by B35 alleles (DL9 and IL9) resulted in more rapid progression. The plasma viral load was higher in B57/58(+) and B27(+) subjects lacking the conserved B57/58- and B27-restricted responses. The presence of certain B57/58-, B27-, and B35-restricted HIV-specific CD8(+) T-cell responses after primary HIV-1 infection better defined disease progression than the HLA genotype alone, suggesting that it is the HIV-specific CD8(+) T cells and not the presence of a particular HLA allele that determine disease progression. Further, the most effective host CD8(+) T-cell responses to HIV-1 were prevalent within an HLA allele, represented a high total allele fraction of the host CD8(+) T-cell response, and targeted conserved regions of HIV-1. These data suggest that vaccine immunogens should contain only conserved regions of HIV-1.

摘要

HLA 等位基因 B57/58、B27 和 B35 与 HIV-1 疾病进展具有最强的遗传关联。这些关系的机制可能是宿主通过 CD8(+)T 细胞反应控制 HIV-1 感染。我们在具有这些等位基因的西雅图初次感染队列研究对象中检查了这些免疫反应。B57/58 等位基因(TW10 和 KF11)和 B27 等位基因(KK10 和 FY10)内保守 HIV 表位的 CD8(+)T 细胞反应延迟了 CD4(+)T 细胞计数的下降(长达 4 到 8 倍),而 B35 等位基因(DL9 和 IL9)呈递的可变表位导致更快的进展。缺乏保守的 B57/58 和 B27 限制反应的 B57/58(+)和 B27(+)受试者的血浆病毒载量更高。初次感染 HIV-1 后,某些 B57/58、B27 和 B35 受限的 HIV 特异性 CD8(+)T 细胞反应的存在比 HLA 基因型更能明确疾病进展,这表明决定疾病进展的是 HIV 特异性 CD8(+)T 细胞,而不是特定的 HLA 等位基因的存在。此外,对 HIV-1 最有效的宿主 CD8(+)T 细胞反应在 HLA 等位基因内普遍存在,代表宿主 CD8(+)T 细胞反应的 HLA 等位基因总分数较高,并且针对 HIV-1 的保守区域。这些数据表明,疫苗免疫原应仅包含 HIV-1 的保守区域。

相似文献

1
Virus-specific CD8+ T-cell responses better define HIV disease progression than HLA genotype.
J Virol. 2010 May;84(9):4461-8. doi: 10.1128/JVI.02438-09. Epub 2010 Feb 10.
4
Pol-Driven Replicative Capacity Impacts Disease Progression in HIV-1 Subtype C Infection.
J Virol. 2018 Sep 12;92(19). doi: 10.1128/JVI.00811-18. Print 2018 Oct 1.
7
Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection.
AIDS. 2003 Dec 5;17(18):2581-91. doi: 10.1097/00002030-200312050-00005.
8
Selective Upregulation of CTLA-4 on CD8+ T Cells Restricted by HLA-B*35Px Renders them to an Exhausted Phenotype in HIV-1 infection.
PLoS Pathog. 2020 Aug 6;16(8):e1008696. doi: 10.1371/journal.ppat.1008696. eCollection 2020 Aug.
9
10
Immunological Control of HIV-1 Disease Progression by Rare Protective HLA Allele.
J Virol. 2022 Nov 23;96(22):e0124822. doi: 10.1128/jvi.01248-22. Epub 2022 Nov 3.

引用本文的文献

1
Control of HIV-1 Replication by CD8 T Cells Specific for Two Novel Pol Protective Epitopes in HIV-1 Subtype A/E Infection.
J Virol. 2022 Oct 12;96(19):e0081122. doi: 10.1128/jvi.00811-22. Epub 2022 Sep 26.
3
Selective Upregulation of CTLA-4 on CD8+ T Cells Restricted by HLA-B*35Px Renders them to an Exhausted Phenotype in HIV-1 infection.
PLoS Pathog. 2020 Aug 6;16(8):e1008696. doi: 10.1371/journal.ppat.1008696. eCollection 2020 Aug.
4
Immune Dysfunction and Coinfection with Human Immunodeficiency Virus and in Yi People.
J Immunol Res. 2018 Jul 2;2018:6989717. doi: 10.1155/2018/6989717. eCollection 2018.
9
KIR and HLA under pressure: evidences of coevolution across worldwide populations.
Hum Genet. 2015 Sep;134(9):929-40. doi: 10.1007/s00439-015-1579-9. Epub 2015 Jun 23.

本文引用的文献

1
Adaptation of HIV-1 to human leukocyte antigen class I.
Nature. 2009 Apr 2;458(7238):641-5. doi: 10.1038/nature07746. Epub 2009 Feb 25.
2
HLA-associated viral mutations are common in human immunodeficiency virus type 1 elite controllers.
J Virol. 2009 Apr;83(7):3407-12. doi: 10.1128/JVI.02459-08. Epub 2009 Jan 19.
4
Introduction: Back to basics: mucosal immunity and novel HIV vaccine concepts.
J Intern Med. 2009 Jan;265(1):5-17. doi: 10.1111/j.1365-2796.2008.02053.x.
6
HIV dynamics in seminal plasma during primary HIV infection.
AIDS Res Hum Retroviruses. 2008 Oct;24(10):1269-74. doi: 10.1089/aid.2008.0014.
9
Central role of reverting mutations in HLA associations with human immunodeficiency virus set point.
J Virol. 2008 Sep;82(17):8548-59. doi: 10.1128/JVI.00580-08. Epub 2008 Jul 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验